Application no. and date | 16782601.5 (espacenet) (Federated) (European Patent Register), 20160418 | Patent/reg. no. and date | DK/EP 3287140, 20210602 | Publication date | 20180228 | Priority no. and date | CN 201510189156, 20150421 | EP pub. no. and date |
EP 3287140 20180228 | Effective date | | Applicant/owner | Beijing Staidson Medical Technology Co., Ltd, Room 501, Building 5, No.36 Jinghai Er Road BDA
Beijing 100176, CN, Staidson (Beijing) Biopharmaceuticals Co., Ltd., No.36 Jinghai Er Road BDA
Beijing 100176, CN | Applicant ref. no. | V345184DK00 | Inventor | TAN, Jianping, No.36 Jinghai Er Road BDA
Beijing 100176, CN, WANG, Bingzhang, No.36 Jinghai Er Road BDA
Beijing 100176, CN | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/18 (2006.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 25/00 (2006.01) | Title | Nervevækstfaktorsammensætning og pulverinjektion | Int. application no. | CN2016079571 | Int. publication no. | WO2016169454 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|